Literature DB >> 15580460

[Infection-related emergencies in oncology].

X Schiel1, C Rieger, H Ostermann.   

Abstract

Infections in immunosuppressed patients have always to be regarded as emergencies, as they have a high rate of complications and mortality. The most important risk factor is severity and duration of granulocytopenia. Risk scores help to identify patients who, despite their immune deficiency have a low risk of complications. Diagnostic measures to identify the causative microorganism and the source of infection is necessary. However, diagnostic investigation must not delay the immediate onset of antimicrobial treatment. Patients often have to be treated empirically as the identification of the causative microorganism or the source of infection are often unknown at the beginning of clinical symptoms. Empirical treatment has to be broad to cover possible microorganisms. Especially meningitis, abdominal infections, sepsis and pneumonia can be regarded as infectiological emergencies. Patients with these infections have to be treated with intensive antimicrobial treatment, taking into account the possible causative agents.

Entities:  

Mesh:

Year:  2005        PMID: 15580460     DOI: 10.1007/s00108-004-1317-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

Review 2.  Pneumonia in neutropenic patients.

Authors:  C P Heussel; H-U Kauczor; A J Ullmann
Journal:  Eur Radiol       Date:  2003-07-24       Impact factor: 5.315

3.  What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia.

Authors:  Brigitte Lamy; Pascal Roy; Gérard Carret; Jean-Pierre Flandrois; Marie Laure Delignette-Muller
Journal:  Clin Infect Dis       Date:  2002-09-10       Impact factor: 9.079

4.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

Review 5.  Empirical antifungal therapy in treating febrile neutropenic patients.

Authors:  John R Wingard
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

6.  Management of fever in neutropenic patients with different risks of complications.

Authors:  Jean Klastersky
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

Review 8.  Nervous system infections in patients with cancer.

Authors:  Amy A Pruitt
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

9.  Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.

Authors:  Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Eric A Hoste; Francis A Colardyn
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

10.  Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Georg Maschmeyer; Thomas Beinert; Dieter Buchheidt; Hermann Einsele; Claus Peter Heussel; Michael Kiehl; Joachim Lorenz
Journal:  Ann Hematol       Date:  2003-09-09       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.